 |
|
Cortical Inflammation in Alzheimer Disease but Not Dementia With Lewy Bodies
Claire E. Shepherd, PhD;
Emma Thiel, BSc;
Heather McCann, DipApplSc;
Antony J. Harding, PhD;
Glenda M. Halliday, PhD
Arch Neurol. 2000;57:817-822.
Background There have been no previous studies on the role of inflammation in the brain for the second most common dementing disorder, dementia with Lewy bodies.
Objective To investigate the degree of cortical inflammation in dementia with Lewy bodies (DLB) compared with Alzheimer disease (AD) and control brains.
Design and Main Outcome Measures Post-mortem tissue collection from a brain donor program using standardized diagnostic criteria. Brains collected from January 1, 1993, through December 31, 1996, were screened and selected only for the presence or absence of tau neuritic plaques. Results of immunohistochemistry for HLA-DR were quantified using area fraction counts. Counts were performed by investigators who were unaware of the diagnosis. Results were compared across groups using analysis of variance and posthoc testing.
Setting A medical research institute in Sydney, Australia.
Patients Eight brains with DLB and without the tau neuritic plaques typical of AD, 10 brains with AD and no Lewy bodies, and 11 nondemented controls without significant neuropathological features were selected from a consecutive sample.
Results Compared with AD, DLB demonstrated significantly less inflammation in the form of HLA-DR–reactive microglia in all cortical regions (P<.001, posthoc). The level of inflammation in DLB was comparable to that seen in controls (P=.54, post hoc).
Conclusions Inflammation appears related to the tau neuritic plaques of AD. Despite similar clinical presentations, therapeutic anti-inflammatory strategies are not likely to be effective for pure DLB.
From the Neuropathology Laboratory, Prince of Wales Medical Research Institute, Randwick, New South Wales, Australia.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
Inflammation in Neurodegenerative Disease: Good, Bad, or Irrelevant?
Lawrence S. Honig
Arch Neurol. 2000;57(6):786-788.
EXTRACT
| FULL TEXT
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(6):902-904.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
A possible role for humoral immunity in the pathogenesis of Parkinson's disease
Orr et al.
Brain 2005;128:2665-2674.
ABSTRACT
| FULL TEXT
Expression of Cellular Prion Protein in the Frontal and Occipital Lobe in Alzheimer's Disease, Diffuse Lewy Body Disease, and in Normal Brain: An Immunohistochemical Study
Rezaie et al.
J. Histochem. Cytochem. 2005;53:929-940.
ABSTRACT
| FULL TEXT
Cerebrospinal Fluid Markers in Dementia With Lewy Bodies Compared With Alzheimer Disease
Gomez-Tortosa et al.
Arch Neurol 2003;60:1218-1222.
ABSTRACT
| FULL TEXT
Lewy body cortical involvement may not always predict dementia in Parkinson's disease
Colosimo et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:852-856.
ABSTRACT
| FULL TEXT
Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders
Schofield et al.
Brain 2003;126:827-840.
ABSTRACT
| FULL TEXT
The Potential for Harm or Benefit From Inflammatory Processes in Stroke
Whitaker
Arch Neurol 2001;58:674-674.
FULL TEXT
Cortical Inflammation in Dementia With Lewy Bodies
Mackenzie et al.
Arch Neurol 2001;58:519-520.
FULL TEXT
Inflammation in Neurodegenerative Disease: Good, Bad, or Irrelevant?
Honig
Arch Neurol 2000;57:786-788.
FULL TEXT
Effect of Anti-inflammatory Medications on Neuropathological Findings in Alzheimer Disease
Halliday et al.
Arch Neurol 2000;57:831-836.
ABSTRACT
| FULL TEXT
|
